Inhaled proteins: challenges and perspectives.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International journal of pharmaceutics

• Publication date

  2013-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijpharm.2013.02.031PMID 23499756
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of dry powder formulations of proteins for inhalation

  2012cited by this paper
• Delivery and Safety of Inhaled Interferon-γ in Idiopathic Pulmonary Fibrosis

  2012cited by this paper
• Drug-lactose binding aspects in adhesive mixtures: controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces.

  2012cited by this paper
• Insulin Detemir

  2012cited by this paper
• Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.

  2012cited by this paper
• Lactose characteristics and the generation of the aerosol.

  2012cited by this paper
• Residual metals cause variability in methionine oxidation measurements in protein pharmaceuticals using LC-UV/MS peptide mapping.

  2012cited by this paper
• State of the art in PEGylation: the great versatility achieved after forty years of research.

  2012cited by this paper
• Comparative pharmacoscintigraphic and pharmacokinetic evaluation of two new formulations of inhaled insulin in type 1 diabetic patients.

  2012cited by this paper
• Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats.

  2012cited by this paper
• Comparative study of clinical pulmonary surfactants using atomic force microscopy.

  2011cited by this paper
• Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.

  2011cited by this paper
• Interactions of formulation excipients with proteins in solution and in the dried state.

  2011cited by this paper
• Highly porous large poly(lactic-co-glycolic acid) microspheres adsorbed with palmityl-acylated exendin-4 as a long-acting inhalation system for treating diabetes.

  2011cited by this paper
• Longer action means better drug: tuning up protein therapeutics.

  2011cited by this paper
• Standards of Medical Care in Diabetes—2011

  2011cited by this paper
• New developments in dry powder pulmonary vaccine delivery.

  2011cited by this paper
• Molecular origins of surfactant-mediated stabilization of protein drugs.

  2011cited by this paper
• Formulation design and in vivo evaluation of dry powder inhalation system of new vasoactive intestinal peptide derivative ([R(15, 20, 21), L(17), A(24,25), des-N(28)]-VIP-GRR) in experimental asthma/COPD model rats.

  2011cited by this paper
• Emerging therapeutic options for asthma.

  2011cited by this paper
• Formation, characterization, and fate of inhaled drug nanoparticles.

  2011cited by this paper
• Lebrikizumab treatment in adults with asthma.

  2011cited by this paper
• Influence of particle size on regional lung deposition--what evidence is there?

  2011cited by this paper
• Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization.

  2011cited by this paper
• Insulin Lung Deposition and Clearance Following Technosphere® Insulin Inhalation Powder Administration

  2011cited by this paper
• Aerosol drug delivery: developments in device design and clinical use.

  2011cited by this paper
• Inhaled Cyclosporine and Pulmonary Function in Lung Transplant Recipients

  2010cited by this paper
• The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

  2010cited by this paper
• Pseudomonas aeruginosa biofilms in cystic fibrosis.

  2010cited by this paper
• Lung deposition of inhaled Alpha-1-proteinase inhibitor (Alpha1-PI) - problems and experience of Alpha1-PI inhalation therapy in patients with hereditary Alpha1-PI deficiency and cystic fibrosis

  2010cited by this paper
• Protein aggregation--pathways and influencing factors.

  2010cited by this paper
• Recombinant immunotherapeutics: current state and perspectives regarding the feasibility and market

  2010cited by this paper
• Mucosal immunization: A realistic alternative

  2010cited by this paper
• Chitosan-based delivery systems for protein therapeutics and antigens.

  2010cited by this paper
• Dried influenza vaccines: Over the counter vaccines

  2010cited by this paper
• Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.

  2010cited by this paper
• Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery.

  2010cited by this paper
• Immunization of Guinea Pigs with Novel Hepatitis B Antigen as Nanoparticle Aggregate Powders Administered by the Pulmonary Route

  2010cited by this paper
• Needle-free influenza vaccination.

  2010cited by this paper
• Formulation and in vitro evaluation of highly dispersive insulin dry powder formulations for lung administration.

  2010cited by this paper
• Formulation strategy and use of excipients in pulmonary drug delivery.

  2010cited by this paper
• Pharmacokinetics and Pharmacodynamics of Inhaled GLP‐1 (MKC253): Proof‐of‐Concept Studies in Healthy Normal Volunteers and in Patients With Type 2 Diabetes

  2010cited by this paper
• Spray drying technique. I: Hardware and process parameters.

  2010cited by this paper
• Lung protease/anti-protease network and modulation of mucus production and surfactant activity.

  2010cited by this paper
• Pulmonary Immunization Using Antigen 85-B Polymeric Microparticles to Boost Tuberculosis Immunity

  2010cited by this paper
• Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures

  2010cited by this paper
• A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.

  2010cited by this paper
• Inhaled insulin: new formulation, new trial.

  2010cited by this paper
• Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.

  2009cited by this paper
• Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation

  2009cited by this paper
• Intrapulmonary potential of polyethylene glycol-modified glucagon-like peptide-1s as a type 2 anti-diabetic agent.

  2009cited by this paper
• Therapeutic application of peptides and proteins: parenteral forever?

  2009cited by this paper
• Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117.

  2009cited by this paper
• Safety and Efficacy of Inhaled Human Insulin (Exubera) During Discontinuation and Readministration of Therapy in Adults with Type 2 Diabetes: A 3-Year Randomized Controlled Trial

  2009cited by this paper
• Short-term safety of somatropin inhalation powder in adults with mild to moderate asthma.

  2009cited by this paper
• Insulin-micro- and nanoparticles for pulmonary delivery.

  2009cited by this paper
• Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody.

  2009cited by this paper
• Treatment of systemic diseases by inhalation of biomolecule aerosols.

  2009cited by this paper
• The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update.

  2009cited by this paper
• Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery.

  2009cited by this paper
• Mechanisms of protein stabilization in the solid state.

  2009cited by this paper
• Romiplostim: a second-generation thrombopoietin agonist.

  2009cited by this paper
• Technosphere® Insulin: Defining the Role of Technosphere Particles at the Cellular Level

  2009cited by this paper
• Chitosan-coated liposomes for delivery to lungs by nebulisation.

  2009cited by this paper
• A study in glycation of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior.

  2008cited by this paper
• Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities

  2008cited by this paper
• Stabilization of IgG1 in spray-dried powders for inhalation.

  2008cited by this paper
• Prandial insulin: is inhaled enough?

  2008cited by this paper
• Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis.

  2008cited by this paper
• Controlling the release of proteins/peptides via the pulmonary route.

  2008cited by this paper
• Inhalable liposomal formulation for vasoactive intestinal peptide.

  2008cited by this paper
• Inhaled Technosphere® Insulin in Comparison to Subcutaneous Regular Human Insulin: Time Action Profile and Variability in Subjects with Type 2 Diabetes

  2008cited by this paper
• Trileucine improves aerosol performance and stability of spray-dried powders for inhalation.

  2008cited by this paper
• Effect of dimethyl-beta-cyclodextrin concentrations on the pulmonary delivery of recombinant human growth hormone dry powder in rats.

  2008cited by this paper
• Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.

  2008cited by this paper
• Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery.

  2008cited by this paper
• Preparation of Active Proteins, Vaccines and Pharmaceuticals as Fine Powders using Supercritical or Near-Critical Fluids

  2008cited by this paper
• Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.

  2008cited by this paper
• New targets for drug development in asthma.

  2008cited by this paper
• New drugs targeting Th2 lymphocytes in asthma

  2008cited by this paper
• Dry powder platform for pulmonary drug delivery

  2008cited by this paper
• Journal of Occupational Medicine and Toxicology a Prospective Study of Decline in Lung Function in Relation to Welding Emissions

  2008cited by this paper
• Drying methods for protein pharmaceuticals.

  2008cited by this paper
• Inhaled insulin--does it become reality?

  2008cited by this paper
• Dry powder inhalation systems for pulmonary delivery of therapeutic peptides and proteins

  2008cited by this paper
• Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.

  2008cited by this paper
• Inhaled nanoparticles--a current review.

  2008cited by this paper
• Stabilization of IgG by supercritical fluid drying: optimization of formulation and process parameters.

  2008cited by this paper
• Formation and Reduction of Acrylamide in Maillard Reaction: A Review Based on the Current State of Knowledge

  2007cited by this paper
• The challenge of drying method selection for protein pharmaceuticals: product quality implications.

  2007cited by this paper
• The AIR® Inhaled Insulin System: System Components and Pharmacokinetic/Glucodynamic Data

  2007cited by this paper
• The development of stable influenza vaccine powder formulations for new needle-free dosage forms

  2007cited by this paper
• Spectroscopic evaluation of the stabilization of humanized monoclonal antibodies in amino acid formulations.

  2007cited by this paper
• Characterization of human insulin microcrystals and their absorption enhancement by protease inhibitors in rat lungs.

  2007cited by this paper
• Inhaled insulin.

  2007cited by this paper
• Summing up 100 years of asthma.

  2007cited by this paper
• Pharmaceutical Particle Engineering via Spray Drying

  2007cited by this paper
• Measles vaccination of macaques by dry powder inhalation.

  2007cited by this paper
• The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response

  2007cited by this paper
• Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody.

  2007cited by this paper

• Impact of Sugar Molecular Weight on the Miscibility and Stability of Lyophilized and Spray-Dried Protein Formulations.

  2025cites this paper
• Exploratory Pharmacokinetic Study of Pegylated Interferon Alfa-2b Aerosolized Inhalation Administration.

  2025cites this paper
• The effects of formulation components on the stability and aerosol performance of spray freeze-dried desmopressin

  2025cites this paper
• Evaluation of intracellularly targeted engineered antioxidant fusion proteins SOD-LCA2 and Prx-LCA2 as promising therapeutic combinations for alleviating and restoring pulmonary oxidative damage.

  2025cites this paper
• Preclinical Safety

  2025cites this paper
• Self-Assembled peptide nanofiber-based nanopharmaceutics for the treatment of viral infections

  2025cites this paper
• Elucidating structure of endogenous phospholipids on in vivo absorption of octreotide following lung administration.

  2025cites this paper
• Insight on the Rise and Raise of Drug Delivery with Special Emphasis on Five Classes of Therapeutics.

  2025cites this paper
• Proteases terapêuticas de planta: aspectos químicos, aplicações e formulações farmacêuticas

  2024cites this paper
• Biologics in Asthma: Emerging Biologics.

  2024cites this paper
• Inhalational Drug Devices: Revisiting the Linchpin of Asthma Management

  2024cites this paper
• Inhalable dry powders of a monoclonal antibody against SARS-CoV-2 virus made by thin-film freeze-drying.

  2024cites this paper
• Effect of atomization on the composition and structure of recombinant humanized collagen type III

  2024cites this paper
• Excipients for Novel Inhaled Dosage Forms: An Overview

  2024cites this paper
• Aerosol Delivery of a Novel Recombinant Modified Superoxide Dismutase Protein Reduces Oxidant Injury and Attenuates Escherichia coli Induced Lung Injury in Rats

  2023cites this paper
• Inhaled multilevel size-tunable, charge-reversible and mucus-traversing composite microspheres as trojan horse: Enhancing lung deposition and tumor penetration

  2023cites this paper
• Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation.

  2023cites this paper
• Nanocarrier-based delivery of peptides: challenges and way forward.

  2023cites this paper
• Structural modifications for the conversion of proteins and peptides into stable dried powder formulations: A review

  2023cites this paper
• Barriers for orally inhaled therapeutic antibodies

  2023cites this paper
• Delivery technology of inhaled therapy for asthma and COPD.

  2023cites this paper
• Enhanced powder dispersion of dual-excipient spray-dried powder formulations of a monoclonal antibody and its fragment for local treatment of severe asthma.

  2023cites this paper
• Pulmonary Application of Novel Antigen-Loaded Chitosan Nano-Particles Co-Administered with the Mucosal Adjuvant C-Di-AMP Resulted in Enhanced Immune Stimulation and Dose Sparing Capacity

  2023cites this paper
• Review of Point-of-Care Platforms for Diabetes: (2) Medications and Devices

  2023cites this paper
• Targeted delivery of inhalable drug particles in the tracheobronchial tree model of a pediatric patient with bronchopneumonia: A numerical study.

  2023cites this paper
• Functionalized zein nanoparticles targeting neonatal Fc receptor to enhance lung absorption of peptides

  2023cites this paper
• Challenges and Strategies to Enhance the Systemic Absorption of Inhaled Peptides and Proteins

  2022cites this paper
• Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment

  2022cites this paper
• Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery

  2022cites this paper
• Production of Biopharmaceutical Dried-Powders using Supercritical CO2 Technology

  2022cites this paper
• Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects

  2022cites this paper
• Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?

  2022cites this paper
• Evaluation of various techniques for production of inhalable dry powders for pulmonary delivery of peptide and protein

  2022cites this paper
• Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.

  2022cites this paper
• Formulation of Spray Dried Enzymes for Dry Powder Inhalers: An Integrated Methodology.

  2022cites this paper
• Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments

  2022cites this paper
• Optimization and Application of an Efficient and Stable Inhalation Exposure System for Rodents

  2022cites this paper
• Aerosol-based Pulmonary Delivery of Therapeutic Molecules from Food Sources: Delivery Mechanism, Research Trends, and the Way Forward

  2021cites this paper
• Inhalable Protein Powder Prepared by Spray-Freeze-Drying Using Hydroxypropyl-β-Cyclodextrin as Excipient

  2021cites this paper
• Inhaled antibodies: formulations require specific development to overcome instability due to nebulization

  2021cites this paper
• A Narrative Review of a Pulmonary Aerosolized Formulation or a Nasal Drop Using Sera Containing Neutralizing Antibodies Collected from COVID-19–Recovered Patients as a Probable Therapy for COVID-19

  2021cites this paper
• Controlled Drug Delivery via the Lung

  2021cites this paper
• Advanced Drug Delivery Systems for Biologics

  2021cites this paper
• Advanced Process Analytical Technology in Combination with Process Modeling for Endpoint and Model Parameter Determination in Lyophilization Process Design and Optimization

  2021cites this paper
• Preparation of Poly-Lactic-Co-Glycolic Acid Nanoparticles in a Dry Powder Formulation for Pulmonary Antigen Delivery

  2021cites this paper
• The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride

  2021cites this paper
• Systemic Delivery of hGhrelin Derivative by Lyophilizate for Dry Powder Inhalation System in Monkeys

  2021cites this paper
• Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines

  2021cites this paper
• Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides

  2021cites this paper
• Application of ultraviolet, visible, and infrared light imaging in protein-based biopharmaceutical formulation characterization and development studies.

  2021cites this paper
• Development of Biopharmaceutical Drug-Device Products

  2020cites this paper
• Toxicological assessment of nanoparticle interactions with the pulmonary system

  2020cites this paper
• Routes of administration for nanocarriers

  2020cites this paper
• Enhanced pulmonary systemic delivery of protein drug via zwitterionic polymer conjugation.

  2020cites this paper
• Chapter 1: Monoclonal Antibodies: Structure, Physicochemical Stability, and Protein Engineering

  2020cites this paper
• Inhalation delivery technology for genome-editing of respiratory diseases

  2020cites this paper
• Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases.

  2020cites this paper
• Application of void forming index (VFI): Detection of the effect of physical properties of dry powder inhaler formulations on powder cohesion.

  2020cites this paper
• Nonclinical Safety Assessment of an Inhaled Formulation of Serelaxin: A Recombinant Human Protein in Rats and Cynomolgus Monkeys (Macaca fascicularis)

  2020cites this paper
• Respiratory Tract: Structure and Attractions for Drug Delivery Using Dry Powder Inhalers

  2020cites this paper
• Inhaled cytotoxic chemotherapy: clinical challenges, recent developments, and future prospects

  2020cites this paper
• Pulmonary Delivery of Biological Drugs

  2020cites this paper
• Developing inhaled protein therapeutics for lung diseases

  2020influential citation
• Antiviral Polymers: Past Approaches and Future Possibilities

  2020cites this paper
• Report on biopharmaceutical profile of recent biotherapeutics and insilco docking studies on target bindings of known aptamer biotherapeutics

  2020cites this paper
• Towards The Development of Biobetter Therapeutic Whole Antibodies

  2019influential citation
• Poly(lactic acid)/poly(lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery

  2019cites this paper
• Amino acid-based stable adalimumab formulation in spray freeze-dried microparticles for pulmonary delivery

  2019cites this paper
• Optimization of supercritical CO2-assisted spray drying technology for the production of inhalable composite particles using quality-by-design principles

  2019cites this paper
• Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer

  2019cites this paper
• Delivery Technologies for Orally Inhaled Products: an Update

  2019cites this paper
• Poly(lactic acid)/poly(lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery

  2019cites this paper
• Nanomedicine-Based Inhalation Treatments for Lung Cancer

  2019cites this paper
• 1H NMR quantification of spray dried and spray freeze-dried saccharide carriers in dry powder inhaler formulations.

  2019cites this paper
• Making Concentrated Antibody Formulations Accessible for Vibrating-Mesh Nebulization.

  2019cites this paper
• Dry-powder formulations of non-covalent protein complexes with linear or miktoarm copolymers for pulmonary delivery.

  2018influential citation
• Effect of amino acids on the stability of spray freeze‐dried immunoglobulin G in sugar‐based matrices

  2018cites this paper
• Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals

  2018cites this paper
• The effect of deuterium oxide on the conformational stability and aggregation of bovine serum albumin

  2018influential citation
• Peptides for biopharmaceutical applications

  2018cites this paper
• Future of nanomedicines for treating respiratory diseases

  2018cites this paper
• Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future

  2018cites this paper
• Bioavailability of protein therapeutics in rats following inhalation exposure: Relevance to occupational exposure limit calculations

  2018cites this paper
• Inhalation treatment of idiopathic pulmonary fibrosis with curcumin large porous microparticles

  2018cites this paper
• Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies

  2018cites this paper
• Biotherapeutics in non‐clinical development: Strengthening the interface between safety, pharmacokinetics‐pharmacodynamics and manufacturing

  2018cites this paper
• Aerosolized Surfactants: Formulation Development and Evaluation of Aerosol Drug Delivery to the Lungs of Infants

  2018cites this paper
• Optimization and scaling-up of ITZ-based dry powders for inhalation

  2017cites this paper
• New perspectives in nanotherapeutics for chronic respiratory diseases

  2017cites this paper
• Lack of a synergistic effect of arginine–glutamic acid on the physical stability of spray-dried bovine serum albumin

  2017cites this paper
• Interleukin-10-Loaded Nano- and Microparticles for the Local Treatment of the Intestinal Mucosa and the Deep Lung

  2017influential citation
• Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

  2017cites this paper
• An In Vitro Examination of the Effects of Altitude on Dry Powder Inhaler Performance

  2017cites this paper
• Systemic delivery of parathyroid hormone (1–34) using spray freeze-dried inhalable particles

  2017cites this paper
• Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes

  2017cites this paper
• Next generation antibody drugs: pursuit of the 'high-hanging fruit'

  2017cites this paper
• AN OVERVIEW OF DRY POWDER INHALATION FOR SYSTEMIC DRUG DELIVERY “ An extensive review in 2005 highlighted the advantages of using a carrier based system for delivery : APIs

  2017cites this paper
• PEGylation, an approach for improving the pulmonary delivery of biopharmaceuticals

  2017cites this paper
• The state‐of‐play and future of antibody therapeutics☆

  2017cites this paper
• This item is the archived peer-reviewed author-version of: Bio-inspired materials in drug delivery: exploring the role of pulmonary surfactant in sIRNA inhalation therapy

  2016cites this paper